Nabriva evaluated the drug, available in oral or intravenous formulations, in two clinical trials with 1,289 community-acquired pneumonia patients. Researchers found the drug worked just as well as another antibiotic, moxifloxacin, in treating the disease.
Some patients had altered electrocardiogram readings after taking Xenleta . The FDA advises against Xenleta for patients with conditions including heart arrhythmias. The drug may also pose a threat to fetuses and is therefore not suitable for pregnant women.
Approval of Xenleta offers pneumonia patients more treatment options, which the FDA says is crucial in addressing the threat of antimicrobial resistance.
More articles on pharmacy:
CMS to cover CAR-T therapy nationwide
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
